BSECompany Update23 Jun 2026 · 23 Jun 2026, 01:59 pm

Intimation of Approval received from Stock Exchanges for listing of 1,98,67,549 equity shares through QIP.

Krishna Institute of Medical Sciences Ltd · 543308

✦ AI Summary▲ PositiveFundraise

Krishna Institute of Medical Sciences Ltd has received approval from both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for the listing of 1,98,67,549 new equity shares. These shares, each with a face value of Rs. 2/-, were issued to qualified institutional buyers through a qualified institutional placement (QIP). This intimation confirms the final procedural step for the shares to be traded on the exchanges following the successful completion of the QIP.

Analysis Scores

Earnings Impact7/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Ltd - 543308 - Intimation Of Approval.

Attachments (1)

📄

29332015-c287-4034-bb1f-17c4a1922b39.pdf

pdf

Download →
View document text
Date: 23rd June 2026 Listing Department Listing & Compliance Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Plot No.C/1, 'G' Block Dalal Street, Mumbai - 400 001. Bandra - Kurla Complex, Mumbai - 400 051. Scrip Code – 543308 Symbol - KIMS ISIN: INE967H01025 ISIN: INE967H01025 Subject: Intimation of approval received for listing of 1,98,67,549 equity shares of Rs. 2/- each to qualified institutional buyers through qualified institutional placement. Ref: Our Intimation to the Stock Exchanges dated 19th June 2026. Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) (as amended), we wish to inform you that Krishna Institute of Medical Sciences has received Listing approval from BSE and NSE (“Stock Exchanges”) towards listing of 1,98,67,549 equity shares of Rs. 2/- each issued to qualified institutional buyers through qualified institutional placement. Please find enclosed herewith the listing approvals received from Stock Exchanges. Kindly take this intimation on your record. Thanking you, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer